Treatment | MAP | HR | SVR | TCVR | LADVR |
---|---|---|---|---|---|
mm Hg | bpm | mm Hg/l/min | mm Hg/ml/min | mm Hg/ml/min | |
Vehicle (n = 19) | 89 ± 4 | 130 ± 6 | 57 ± 5 | 0.62 ± 0.05 | 3.1 ± 0.4 |
Naratriptan (n = 7) | 94 ± 4 | 134 ± 10 | 62 ± 6 | 0.63 ± 0.08 | 4.0 ± 0.6 |
Rizatriptan (n = 7) | 95 ± 3 | 132 ± 9 | 52 ± 3 | 0.39 ± 0.04* | 3.3 ± 1.1 |
Sumatriptan (n = 7) | 84 ± 5 | 122 ± 10 | 55 ± 7 | 0.63 ± 0.06 | 3.9 ± 0.6 |
bpm, beats per minute.
↵* P < 0.05 versus vehicle group assessed by one-way ANOVA followed by Dunnett's test.